Emerging studies suggest this peptide, a dual stimulator targeting both incretin and glucose-dependent insulinotropic polypeptide , appears to provide a significant step forward for weight treatment. https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide